Oncologics - GEN - Genetic Engineering and Biotechnology News

Bayer

Top 10 Ambition: Bayer Aims for $10 Billion in Cancer Drug Sales by 2030

Oncologics

Olema Plans Pivotal Trial for Two-Prong Breast Cancer Treatment

pencil eraser erasing tumor

Oncologics

Cancer Cell-Based Vaccine Kills Tumors and Induces Long-Term Immunity

Oncologics

Metastatic Colorectal Cancers in Mice Virtually Eliminated Using Immunotherapy and Experimental Drug Combo

White Blood Cell

Oncologics

Gut Microbiome Drives Production of Neutrophils after Prolonged Chemotherapy

Immunotherapy

Oncologics

Somatic Cell Copy Number Changes in HNSC Cancer Predict Immunotherapy Response

RNA strand

Precision Medicine

SPAC Revival: AUM Pursues $400M Deal to Develop Cancer Pipeline

cancer patient and doctor

Oncologics

Protein-Degradation CELMoD Drug Prospects Aided by New Study Findings

Oncologics

DNA-Based Nanotransporters Deliver Precise Concentrations of Drug

Cancer cell

Oncologics

Pre-Surgery Immunotherapy Combo Cleared Tumors in Stage III Melanoma Patients

Dropper; liquid medicine

Oncologics

Update on Biomed Innovation in Brazil

Oncologics

Acid-Seeking Peptide Targets Immunotherapy Specifically to Tumors

Oncologics

Oncometabolite Disarms Immune System to Promote Tumor Growth

Prostate cancer cells, SEM

Oncologics

Prostate Cancer Treatment May Rewire Tumor Engine, Potentially Increasing Aggressiveness

Cancer

Cancer

Tumor-Informed Liquid Biopsies to Transform Oncology Drug Development

12 3...29 Page 1 of 29